phosphorylethanolamine has been researched along with B16 Melanoma in 7 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therefore, cystemustine-treated B16 melanoma tumors acquire a new Plp metabolism phenotype, a mechanism that could participate in tumor cell redifferentiation and/or survival." | 1.31 | Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. ( De Latour, M; Demidem, A; Madelmont, JC; Morvan, D; Papon, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luna, ACL | 1 |
| Santos Filho, JRA | 1 |
| Hesse, H | 1 |
| Neto, SC | 2 |
| Chierice, GO | 2 |
| Maria, DA | 2 |
| Mambelli, LI | 1 |
| Teixeira, SF | 1 |
| Jorge, SD | 1 |
| Kawamura, B | 1 |
| Meneguelo, R | 2 |
| Barbuto, JAM | 1 |
| de Azevedo, RA | 1 |
| Ferreira, AK | 2 |
| Tata, A | 1 |
| Fernandes, AM | 1 |
| Santos, VG | 1 |
| Alberici, RM | 1 |
| Araldi, D | 1 |
| Parada, CA | 1 |
| Braguini, W | 1 |
| Veronez, L | 1 |
| Silva Bisson, G | 1 |
| Reis, FH | 1 |
| Alberici, LC | 1 |
| Eberlin, MN | 1 |
| Marques, FL | 1 |
| Radin, A | 1 |
| Filho, OM | 1 |
| Morvan, D | 2 |
| Demidem, A | 2 |
| Madelmont, JC | 2 |
| Degani, H | 1 |
| DeJordy, JO | 1 |
| Salomon, Y | 1 |
| Papon, J | 1 |
| De Latour, M | 1 |
7 other studies available for phosphorylethanolamine and B16 Melanoma
| Article | Year |
|---|---|
Modulation of pro-apoptotic effects and mitochondrial potential on B16F10 cells by DODAC/PHO-S liposomes.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Cell Line, Tumor; Cytotoxins; Ethanolamines; Liposomes; | 2018 |
Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspases; Cell Cycle Checkpoints; Cell Mov | 2018 |
Nanoassisted laser desorption-ionization-MS imaging of tumors.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Ethanolamines; Humans; Image Processing, Computer-Assi | 2012 |
Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Eth | 2012 |
Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study.
Topics: Animals; Antineoplastic Agents; Cell Survival; Ethanolamines; Glycerylphosphorylcholine; Magnetic Re | 2003 |
Determination of the response of melanoma cells to melanocyte stimulating hormone by 31P nuclear magnetic resonance spectroscopy.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Colforsin; Cyclic AMP; Ethanolamines; Magnetic Resonance Spect | 1993 |
Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Topics: Animals; Antineoplastic Agents; Cell Division; Choline; Ethanolamines; Male; Melanoma, Experimental; | 2002 |